Literature DB >> 16043215

Impact of surgical approach on the management of macroscopic early ovarian borderline tumors.

Patrice Desfeux1, Sophie Camatte, Gilles Chatellier, Bernard Blanc, Denis Querleu, Fabrice Lécuru.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the impact of the surgical approach on the management and outcomes of patients with early borderline ovarian tumors (BOTs).
MATERIAL AND METHODS: We retrospectively reviewed the medical charts of patients with stage Ia to Ic BOT treated surgically between January 1, 1985, and December 31, 2001. We compared patients initially managed by laparoscopy vs. laparotomy in terms of potentially harmful procedures and quality of staging.
RESULTS: Of the 118 included patients, 48 (41%) had laparoscopy for initial surgery, 54 (45%) had laparotomy, and 16 (14%) had conversion from laparoscopy to laparotomy. Conservative treatment (57% of patients) was more common with laparoscopy (vs. laparotomy, P < 0.05) and in women older than 44 years (vs. younger than 44 years, P < 0.001). Intraoperative tumor rupture occurred in 9% of patients and was not associated with the surgical approach (P = 0.1). Bag extraction was used in 19 (40%) of the 48 laparoscopy patients. Staging was incomplete in 73% of patients overall. By univariate analysis, better quality of staging was associated with bilateral adnexectomy, age >44 years, laparotomy, hysterectomy, and treatment after 1995. By multivariate analysis, bilateral adnexectomy or hysterectomy was associated with better staging. Mean follow-up was 40 months, during which recurrence and survival rates were similar in the laparoscopy and laparotomy groups.
CONCLUSION: Staging of macroscopic early stage BOTs was better in patients requiring radical surgery. After adjustment on disease severity, type of surgical access was not related to staging quality.

Entities:  

Mesh:

Year:  2005        PMID: 16043215     DOI: 10.1016/j.ygyno.2005.04.043

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center.

Authors:  Duygu Kavak Cömert; Işın Üreyen; Alper Karalok; Tolga Taşçı; Osman Türkmen; Reyhan Öcalan; Taner Turan; Gökhan Tulunay
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

2.  Management of a suspicious adnexal mass: a clinical practice guideline.

Authors:  J E Dodge; A L Covens; C Lacchetti; L M Elit; T Le; M Devries-Aboud; M Fung-Kee-Fung
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

Review 3.  Natural history of ovarian cancer.

Authors:  Arturo Novoa Vargas
Journal:  Ecancermedicalscience       Date:  2014-09-25

4.  Clinicopathological aspects of patients with recurrence of borderline ovarian tumors.

Authors:  Sumin Oh; Ran Kim; Yoo-Kyung Lee; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song
Journal:  Obstet Gynecol Sci       Date:  2015-03-16

5.  Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.

Authors:  Margarita Romeo; Francesc Pons; Pilar Barretina; Joaquim Radua
Journal:  World J Surg Oncol       Date:  2013-01-23       Impact factor: 2.754

Review 6.  Controversies in borderline ovarian tumors.

Authors:  Seok Ju Seong; Da Hee Kim; Mi Kyoung Kim; Taejong Song
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

7.  Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study.

Authors:  Mehmet Gokcu; Kemal Gungorduk; Osman Aşıcıoğlu; Nilüfer Çetinkaya; Tayfun Güngör; Gonca Pakay; Zeliha Fırat Cüylan; Tayfun Toptaş; Ramazan Özyurt; Elif Ağaçayak; Aykut Ozdemir; Onur Erol; Anıl Turan; Varol Gülseren; Mehmet Sait İcen; Taylan Şenol; Hakan Güraslan; Burcu Yücesoy; Ahmet Sahbaz; Ozgu Gungorduk; Berhan Besimoğlu; Kaan Pakay; Osman Temizkan; Muzaffer Sancı; Tayup Şimşek; Mehmet Mutlu Meydanlı; Mehmet Harma; Levent Yaşar; Birtan Boran; Aysel Derbent Uysal; Ateş Karateke
Journal:  J Ovarian Res       Date:  2016-10-18       Impact factor: 4.234

Review 8.  Borderline ovarian tumours: management in the era of fertility-sparing surgery.

Authors:  Mattia Maramai; Fabio Barra; Mario Valenzano Menada; Sara Stigliani; Melita Moioli; Sergio Costantini; Simone Ferrero
Journal:  Ecancermedicalscience       Date:  2020-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.